Literature DB >> 17337201

Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma.

Antonio E Martin-Ucar1, Apostolos Nakas, John G Edwards, David A Waller.   

Abstract

OBJECTIVE: To compare the outcomes of extrapleural pneumonectomy (EPP) and radical pleurectomy/decortication (P/D) for N2 malignant pleural mesothelioma (MM). PATIENTS AND METHODS: In a retrospective case-control study we analysed the results of the 57 patients [49 male and 8 female, median age 59 (range 14-70) years] who underwent radical surgery for MM found to have pathological N2 disease over a 7-year-period. EPP was performed on 45 and P/D on 12 patients. Prognostic factors, postoperative course, pathological data and postoperative survival were analysed.
RESULTS: Those in the P/D group were significantly older (median age 62 vs 58 years, p=0.03) than in the EPP group. There was no difference in postoperative hospital stay (p=0.1) nor T stage (p=0.7) between the groups. There were no significant differences in the proportion of patients undergoing some adjuvant therapy in each group (p=0.2). Mean survival from diagnosis was 15 months in the EPP group and 16 months for those who underwent P/D (p=0.4).
CONCLUSIONS: Preservation of the lung during radical surgery for N2 MM does not compromise survival even in an older group population. We therefore now have ceased to perform EPP in cases of N2 disease and we make every effort to accurately stage patients with mediastinoscopy to identify them.

Entities:  

Mesh:

Year:  2007        PMID: 17337201     DOI: 10.1016/j.ejcts.2007.01.064

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery.

Authors:  Emanuela Taioli; Maaike van Gerwen; Meredith Mihalopoulos; Gil Moskowitz; Bian Liu; Raja Flores
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 2.  A systematic review of lung-sparing extirpative surgery for pleural mesothelioma.

Authors:  Elaine Teh; Francesca Fiorentino; Carol Tan; Tom Treasure
Journal:  J R Soc Med       Date:  2011-02       Impact factor: 5.344

3.  Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy?

Authors:  Mehmet Ali Bedirhan; Levent Cansever; Adalet Demir; Süleyman Ceyhan; Hasan Akın; Halide Nur Urer; Aysun Olçmen; Celalettin Kocatürk; Ibrahim Dinçer
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

4.  Extrapleural pneumonectomy and extended pleurectomy/decortication for malignant pleural mesothelioma: the Memorial Sloan-Kettering Cancer Center approach.

Authors:  Valerie W Rusch
Journal:  Ann Cardiothorac Surg       Date:  2012-11

Review 5.  Malignant mesothelioma: current status and perspective in Japan and the world.

Authors:  Seiki Hasegawa; Fumihiro Tanaka
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-07-08

6.  Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?

Authors:  Joerg Lindenmann; Veronika Matzi; Nicole Neuboeck; Udo Anegg; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-21

7.  Do we need a revised staging system for malignant pleural mesothelioma? Analysis of the IASLC database.

Authors:  Valerie W Rusch; Dorothy Giroux
Journal:  Ann Cardiothorac Surg       Date:  2012-11

8.  High-pressure intrapleural chemotherapy: feasibility in the pig model.

Authors:  Olivier Facy; Pierre-Benoit Pages; Pablo Ortega-Deballon; Guy Magnin; Sylvain Ladoire; Bernard Royer; Bruno Chauffert; Alain Bernard
Journal:  World J Surg Oncol       Date:  2012-02-06       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.